At Nixon Peabody, our priority is to attract, retain, and promote talented individuals from a wide range of racial, ethnic, social, economic, religious, and personal backgrounds, genders and sexual orientations. Therefore, we encourage talented individuals with diverse backgrounds and experiences to apply.
Our Community Development Finance practice is one of the largest of its kind in the nation, and among the foremost legal authorities in transactions involving tax credit financing and other community development programs – either individually or in combination with other incentives. Qualified candidates will be motivated self-starters with strong academic credentials, superb judgment and communication skills, a commitment to exceptional client service, and will have the ability to thrive in a demanding work environment.
At Nixon Peabody, our attorneys are given the opportunity to take the lead on interesting matters and provided with the opportunity to work on career-enhancing transactions that both challenge and excite them. Our diverse workforce encourages collaboration and teamwork. Our entrepreneurial culture inspires attorneys at all levels to build relationships both inside and outside the firm, setting the foundation for a long and exciting career with us.
A career at Nixon Peabody is the opportunity to do work that creates positive impact. It’s a chance to use your knowledge to shape what’s ahead, to innovate, to learn at a firm that taps into the power of collaboration and collective thinking. For more information, please visit – https://www.nixonpeabody.com/work/community-development-finance
Location: Albany, NY; Boston, MA; Buffalo, NY; Chicago, IL; Jericho, NY; Los Angeles, CA; Manchester, NH; New York, NY; Providence, RI; Rochester, NY; San Francisco, CA; Washington, DC
Our Community Development Finance Practice Group is seeking to hire an associate to join our national new markets tax credit practice. As noted above, location is flexible and a variety of remote work options are available.
The ideal candidate will have three to five years of transactional experience in real estate or community development finance projects. The successful candidate will work primarily with our New Markets Tax Credit team and will focus on advising investors, community development entities, project sponsors, leverage lenders, and/or other lender participants in connection with the structuring of multiple sources of financing, including tax credits and other government incentives, to be used in aiding commercial development and revitalizing underserved communities across the country. Knowledge of real estate finance, government incentive programs, partnerships and limited liability companies, and an aptitude for analyzing financial projections all will allow the successful attorney to provide real value to our clients. Prior law firm or national accounting firm experience is a plus.
Nixon Peabody LLP is an Equal Opportunity / Affirmative Action Employer: Disability / Female / Gender Identity / Minority / Sexual Orientation / Veteran. Pursuant to the San Francisco Fair Chance Ordinance and the Los Angeles Fair Chance Initiative, we will consider for employment qualified applicants with arrest and conviction records.
To comply with Federal law, Nixon Peabody participates in E-Verify. All newly-hired employees are verified through this electronic system established by the Department of Homeland Security (DHS) and the Social Security Administration (SSA) to confirm their identity and employment eligibility. Please refer to the Notice of E-Verify Participation and the Right to Work posters on the Nixon Peabody Careers page for more information.
All applicants for employment with NP, unless they receive an approved exemption as an accommodation for a medical issue or sincerely held religious belief, must be “Up to Date” with respect to their COVID-19 vaccinations by their hire date. “Up to Date” currently means that the applicant has completed the Moderna or Pfizer-BioNTech primary vaccine series, plus a booster vaccine, if eligible, or the Johnson & Johnson Janssen one dose primary vaccine, plus a booster vaccine, if eligible.